[Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy]. FE 2016, 17 (2), 67-80. https://doi.org/10.7175/fe.v17i2.1251.